Pfizer

  • Somavert 2016 report

    Somavert 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 19 Pages The 5 Key Questions Addressed by this Report:...

  • Sutent 2016 report

    Sutent 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Thrombin 2016 report

    Thrombin 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 28 Pages The 5 Key Questions Addressed by this Report:...

  • Torisel 2016 report

    Torisel 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 22 Pages The 5 Key Questions Addressed by this Report:...

  • Toviaz 2016 report

    Toviaz 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Trumenba 2016 report

    Trumenba 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Viagra 2016 report

    Viagra 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Xalkori 2016 report

    Xalkori 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Xeljanz 2016 report

    Xeljanz 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Xyntha Solofuse 2016 report

    Xyntha Solofuse 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 26 Pages The 5 Key Questions Addressed by this...

  • Bosulif 2015 report

    Bosulif 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 25 Pages The 5 Key Questions Addressed by this...

  • Chantix 2015 report

    Chantix 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 20 Pages The 5 Key Questions Addressed by this Report:...